VanEck Associates’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $182M | Sell |
|
|||||
|
2025
Q1 | $305M | Sell |
|
|||||
|
2024
Q4 | $513M | Sell |
|
|||||
|
2024
Q3 | $527M | Buy |
|
|||||
|
2024
Q2 | $380M | Buy |
|
|||||
|
2024
Q1 | $431M | Buy |
|
|||||
|
2023
Q4 | $207M | Buy |
|
|||||
|
2023
Q3 | $26.2M | Buy |
|
|||||
|
2023
Q2 | $23.5M | Buy |
|
|||||
|
2023
Q1 | $23.6M | Sell |
|
|||||
|
2022
Q4 | $35M | Sell |
|
|||||
|
2022
Q3 | $36.4M | Buy |
|
|||||
|
2022
Q2 | $38.1M | Sell |
|
|||||
|
2022
Q1 | $134M | Sell |
|
|||||
|
2021
Q4 | $210M | Buy |
|
|||||
|
2021
Q3 | $183M | Buy |
|
|||||
|
2021
Q2 | $186M | Buy |
|
|||||
|
2021
Q1 | $149M | Buy |
|
|||||
|
2020
Q4 | $123M | Buy |
|
|||||
|
2020
Q3 | $110M | Buy |
|
|||||
|
2020
Q2 | $61.7M | Buy |
|
|||||
|
2020
Q1 | $56.5M | Sell |
|
|||||
|
2019
Q4 | $118M | Buy |
|
|||||
|
2019
Q3 | $79.5M | Buy |
|
|||||
|
2019
Q2 | $40M | Buy |
|
|||||
|
2019
Q1 | $34.7M | Buy |
|
|||||
|
2018
Q4 | $36M | Buy |
|
|||||
|
2018
Q3 | $40.1M | Sell |
|
|||||
|
2018
Q2 | $36.7M | Buy |
|
|||||
|
2018
Q1 | $29.2M | Sell |
|
|||||
|
2017
Q4 | $46.2M | Sell |
|
|||||
|
2017
Q3 | $50.4M | Buy |
|
|||||
|
2017
Q2 | $43.8M | Buy |
|
|||||
|
2017
Q1 | $41.1M | Buy |
|
|||||
|
2016
Q4 | $37.4M | Buy |
|
|||||
|
2016
Q3 | $20.6M | Buy |
|
|||||
|
2016
Q2 | $13.2M | Sell |
|
|||||
|
2016
Q1 | $12.6M | Sell |
|
|||||
|
2015
Q4 | $18.2M | Buy |
|
|||||
|
2015
Q3 | $15.3M | Sell |
|
|||||
|
2015
Q2 | $17.7M | Buy |
|
|||||
|
2015
Q1 | $14.4M | Sell |
|
|||||
|
2014
Q4 | $14.7M | Sell |
|
|||||
|
2014
Q3 | $18.1M | Buy |
|
|||||
|
2014
Q2 | $15.7M | Buy |
|
|||||
|
2014
Q1 | $13.4M | Buy |
|
|||||
|
2013
Q4 | $13.3M | Sell |
|
|||||
|
2013
Q3 | $12.8M | Buy |
|
|||||
|
2013
Q2 | $11.6M | Buy |
|